Skip to content
Industry
This is research, not advice. We’re not SEBI-registered.

Enovix share price today

Enovix Corporation · ENVX · Industrials · Electrical Equipment & Parts · price as of the 4 November 2026 close, updated every trading day · results updated weekly · All US stock lists

Enovix share price: $2.79 at the close on 4 November 2026, −70.8% in a year.

$2.79Price −70.8% in a year
$9.0 MRevenue (Jul 2026) +20.8% on a year ago
−$43.1 MProfit (Jul 2026), incl. one-off one-off item, see below
−479.8%Operating margin +96.4 points on a year ago
−57%ROE FY25
−19.3%ROIC against a 11.6% cost of capital: −30.9 points

Enovix Corporation's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer.

Biggest thing to watch: the price is not yet in a clear uptrend, so timing is the risk more than the business.

The price has been between phases. Over the last four quarters, results have been improving. What will decide it: the next one or two quarters of results.

What is the Enovix share price today?

Enovix Corporation's share price was $2.79 at the close on 4 November 2026. That is 45.1% below its average price over the last 200 trading days. In the last 52 weeks it traded between $2 and $10, and at that close it sat 5% of the way up from that low.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). The phase helps read everything below.

Over the past 13 weeks it has done worse than the S&P 500, and it has been behind for 20 weeks running.

Nov 2026: $2.79, 45.1% below its 200-day average.

  • Price $2.79
  • 50-day avg $2.93
  • 200-day avg $5.08
Nov 2026: $2.79, 45.1% below its 200-day average.
WeekPrice50-day avg200-day avg
11 Jul 2025$14.07––
18 Jul 2025$15.54––
25 Jul 2025$14.69––
1 Aug 2025$10.71––
8 Aug 2025$10.78––
15 Aug 2025$10.21––
22 Aug 2025$10.51––
29 Aug 2025$9.62––
5 Sep 2025$9.19––
12 Sep 2025$8.14––
19 Sep 2025$10.09$11.36–
26 Sep 2025$10.09$10.90–
3 Oct 2025$11.92$10.52–
10 Oct 2025$12.07$10.36–
17 Oct 2025$11.21$10.49–
24 Oct 2025$12.32$10.60–
31 Oct 2025$11.99$10.77–
7 Nov 2025$9.56$10.80–
14 Nov 2025$8.04$10.72–
21 Nov 2025$7.47$10.59–
28 Nov 2025$7.79$10.45–
5 Dec 2025$8.96$10.25–
12 Dec 2025$8.64$10.08–
19 Dec 2025$7.86$9.59–
26 Dec 2025$7.63$9.22–
2 Jan 2026$7.89$8.88–
9 Jan 2026$7.92$8.53–
16 Jan 2026$8.24$8.17–
23 Jan 2026$7.53$7.98–
30 Jan 2026$6.62$7.88–
6 Feb 2026$6.38$7.77–
13 Feb 2026$5.92$7.62–
20 Feb 2026$5.95$7.40–
27 Feb 2026$5.27$7.11–
6 Mar 2026$4.85$6.85–
13 Mar 2026$4.94$6.56–
20 Mar 2026$4.86$6.25–
27 Mar 2026$5.23$5.97–
2 Apr 2026$5.06$5.75–
10 Apr 2026$6.09$5.59–
17 Apr 2026$6.62$5.55–
24 Apr 2026$6.61$5.61$8.80
1 May 2026$6.77$5.67$8.60
8 May 2026$6.61$5.73$8.39
15 May 2026$6.11$5.89$8.20
22 May 2026$6.68$6.01$8.06
29 May 2026$7.98$6.22$8.00
5 Jun 2026$7.28$6.53$7.95
12 Jun 2026$6.66$6.70$7.86
18 Jun 2026$7.08$6.81$7.80
26 Jun 2026$5.95$6.83$7.72
2 Jul 2026$5.36$6.77$7.67
10 Jul 2026$5.20$6.63$7.56
17 Jul 2026$4.72$6.45$7.42
24 Jul 2026$3.95$6.22$7.25
31 Jul 2026$4.09$6.00$7.03
7 Aug 2026$4.70$5.76$6.84
14 Aug 2026$4.39$5.40$6.66
21 Aug 2026$3.38$5.01$6.45
28 Aug 2026$3.36$4.68$6.28
4 Sep 2026$3.32$4.36$6.16
11 Sep 2026$3.10$4.14$6.07
18 Sep 2026$2.99$3.91$5.96
25 Sep 2026$2.87$3.70$5.82
2 Oct 2026$2.80$3.52$5.67
9 Oct 2026$2.46$3.37$5.54
16 Oct 2026$2.49$3.20$5.41
23 Oct 2026$2.79$2.99$5.27
30 Oct 2026$3.15$2.95$5.15
4 Nov 2026$2.79$2.93$5.08
Weekly closing price ($) with its 50-day and 200-day averages. 1-year window.

Week by week since 2025: did it beat the S&P 500 over the past 13 weeks?

Ahead in 7 of 57 weeks

Week by week since 2025: did it beat the S&P 500 over the past 13 weeks?
Week13-week return vs S&P 500
11 Jul 2025no S&P 500 reading
18 Jul 2025no S&P 500 reading
25 Jul 2025no S&P 500 reading
1 Aug 2025no S&P 500 reading
8 Aug 2025no S&P 500 reading
15 Aug 2025no S&P 500 reading
22 Aug 2025no S&P 500 reading
29 Aug 2025no S&P 500 reading
5 Sep 2025no S&P 500 reading
12 Sep 2025no S&P 500 reading
19 Sep 2025no S&P 500 reading
26 Sep 2025no S&P 500 reading
3 Oct 2025no S&P 500 reading
10 Oct 2025−18.9%
17 Oct 2025−33.7%
24 Oct 2025−22.4%
31 Oct 2025+2.2%
7 Nov 2025−16.6%
14 Nov 2025−25.7%
21 Nov 2025−31.1%
28 Nov 2025−25.0%
5 Dec 2025−8.4%
12 Dec 2025+2.4%
19 Dec 2025−24.6%
26 Dec 2025−28.7%
2 Jan 2026−35.9%
9 Jan 2026−40.7%
16 Jan 2026−30.6%
23 Jan 2026−40.6%
30 Jan 2026−46.2%
6 Feb 2026−36.2%
13 Feb 2026−27.8%
20 Feb 2026−25.0%
27 Feb 2026−32.7%
6 Mar 2026−43.9%
13 Mar 2026−40.0%
20 Mar 2026−33.5%
27 Mar 2026−23.3%
2 Apr 2026−31.9%
10 Apr 2026−21.0%
17 Apr 2026−22.3%
24 Apr 2026−15.8%
1 May 2026−1.9%
8 May 2026−3.2%
15 May 2026−5.2%
22 May 2026+4.1%
29 May 2026+41.1%
5 Jun 2026+40.4%
12 Jun 2026+22.8%
18 Jun 2026+30.5%
26 Jun 2026−1.2%
2 Jul 2026−7.6%
10 Jul 2026−25.7%
17 Jul 2026−33.4%
24 Jul 2026−43.7%
31 Jul 2026−43.2%
7 Aug 2026−33.7%
14 Aug 2026−33.2%
21 Aug 2026−52.1%
28 Aug 2026−59.6%
4 Sep 2026−58.8%
11 Sep 2026−56.5%
18 Sep 2026−59.8%
25 Sep 2026−57.6%
2 Oct 2026−51.1%
9 Oct 2026−55.8%
16 Oct 2026−49.9%
23 Oct 2026−32.2%
30 Oct 2026−24.1%
4 Nov 2026−39.8%
Each bar is one week, from 2025 to now (57 weeks with a reading). Green means the stock's return over the previous 13 weeks beat the S&P 500; red means it trailed. The colour is strongest at a gap of 25 percentage points or more. A gap means there is no reading for that week.

Over the last 1 year the share price moved −80% while the S&P 500 moved +23%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 18 June 2026. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

What dividend does Enovix pay?

Enovix Corporation pays no dividend. In the last 12 reported quarters it declared no dividend per share, so there is no payout history to chart and no yield to show. Companies like this usually keep their earnings in the business, so the cash-flow sections show where that cash goes.

Which stock lists is Enovix on?

Enovix is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list.

Is Enovix profitable?

Enovix Corporation posted a net loss of $43.1 M in the Jul 2026 quarter. That quarter includes a one-off gain bigger than its revenue, so the comparison with last year does not reflect normal business. The full FY25 year was a loss of $157 M. That loss is 477.2% of the quarter's revenue.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

The same quarter a year earlier lost $44.5 M. 12 of the last 12 reported quarters were loss-making.

Read this profit with care: at −$43.1 M it is bigger than the quarter's whole revenue of $9.0 M. No business earns more than it takes in from sales, so this is a one-off item (for example a debt settlement, a tax write-back or an asset sale), not money the business earned. The underlying business is running at a −479.8% operating margin. The jump on last year, and any P/E built on this profit, come from the one-off, not from a real turn in earnings.

FY25 profit −$157 M

  • Net profit −$157 M
FY25 profit −$157 M
QuarterNet profit
FY23−$51.6 M
FY23−$214 M
FY24−$222 M
FY25−$157 M
Net profit each year, $ M. 4-year window. A grey bar is lower than the year before.

Jul 2026: −$43.1 M

  • Net profit (quarterly) −$43.1 M
Jul 2026: −$43.1 M
QuarterNet profit (quarterly)
Oct 2023−$16.2 M
Dec 2023−$60.0 M
Mar 2024−$46.4 M
Jun 2024−$116 M
Sep 2024−$22.5 M
Dec 2024−$37.5 M
Mar 2025−$23.5 M
Jun 2025−$44.5 M
Sep 2025−$53.7 M
Dec 2025−$35.0 M
Apr 2026−$38.3 M
Jul 2026−$43.1 M
Net profit each quarter, $ M. Last 12 quarters. A grey bar is lower than the quarter before.

How much revenue does Enovix make, and is it growing?

Enovix Corporation reported $9.0 M of revenue in the Jul 2026 quarter, +20.8% on the same quarter a year earlier. That is the 5th quarter in a row with growth on the year before. Over 2 years it has grown 126.5% a year on average. The last full year, FY25, came in at $31.8 M.

Revenue is everything the company billed its customers in the period.

The last four reported quarters add to $35.9 M.

FY25 revenue was $31.8 M, +37.9% on the year before.

FY25 revenue $31.8 M (+37.9% on the year before), 126.5% a year over 2 years

  • Revenue $31.8 M
FY25 revenue $31.8 M (+37.9% on the year before), 126.5% a year over 2 years
QuarterRevenue
FY23$6.2 M
FY23$7.6 M
FY24$23.1 M
FY25$31.8 M

Growth on a year earlier

  • Growth on a year earlier 37.9%
Growth on a year earlier
QuarterGrowth on a year earlier
FY23–
FY2323.3%
FY24201.9%
FY2537.9%
Top: revenue each year, $ M. Below: growth on the year before, %. 4-year window. A grey bar is lower than the year before.

Jul 2026: $9.0 M (+20.8% on a year earlier), the 5th quarter in a row of growth

  • Revenue (quarterly) $9.0 M
Jul 2026: $9.0 M (+20.8% on a year earlier), the 5th quarter in a row of growth
QuarterRevenue (quarterly)
Oct 2023$0.2 M
Dec 2023$7.4 M
Mar 2024$5.3 M
Jun 2024$3.8 M
Sep 2024$4.3 M
Dec 2024$9.7 M
Mar 2025$5.1 M
Jun 2025$7.5 M
Sep 2025$8.0 M
Dec 2025$11.3 M
Apr 2026$7.6 M
Jul 2026$9.0 M

Growth on a year earlier

  • Growth on a year earlier 20.8%
Growth on a year earlier
QuarterGrowth on a year earlier
Oct 20232,400%
Dec 2023–
Mar 2024–
Jun 20248,871.4%
Sep 20242,058.5%
Dec 202431.6%
Mar 2025−3.3%
Jun 202598.2%
Sep 202585.1%
Dec 202515.9%
Apr 202649.1%
Jul 202620.8%
Top: revenue each quarter, $ M. Below: growth on the same quarter a year earlier, %. Last 12 quarters. A grey bar is lower than the quarter before.

Recent pace: the last four quarters grew +42.7% on average, against 126.5% a year over the longer run, so this year is growing slower than its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew +34.9%, against +46.9% a year over the last 8 quarters (rolling over).

How much of every $100 of sales does Enovix keep?

Enovix Corporation's operating margin was −479.8% in the Jul 2026 quarter, 96.4 percentage points higher than the same quarter a year ago. Across 4 years it has been between −2,656.0% and −554.8%. The latest quarter is above every full year in that period.

Operating margin is what is left from every $100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why the margin moved: operating margin changed +96.4 percentage points on the year while gross margin changed −11.6 points. So the gain came mostly from costs below the gross margin, such as staff and overheads, measured against sales.

FY25: −554.8%, within a range of −2,656.0% to −554.8% over 4 years

  • Operating margin −554.8%
FY25: −554.8%, within a range of −2,656.0% to −554.8% over 4 years
QuarterOperating margin
FY23−2,048.7%
FY23−2,656%
FY24−782.5%
FY25−554.8%

Change on the year before (points)

  • Change on the year before (points) +227.7 pts
Change on the year before (points)
QuarterChange on the year before (points)
FY23–
FY23−607.3 pts
FY24+1,873.5 pts
FY25+227.7 pts
Operating margin each year, % (top). Below: change on the year before, in percentage points. 4-year window.

Jul 2026: operating margin −479.8% (+96.4 points on a year earlier)

  • Operating margin −479.8%
Jul 2026: operating margin −479.8% (+96.4 points on a year earlier)
QuarterOperating margin
Oct 2023−23,681%
Dec 2023−473.9%
Mar 2024−1,294.3%
Jun 2024−1,343%
Sep 2024−1,056.4%
Dec 2024−355.2%
Mar 2025−834.8%
Jun 2025−576.2%
Sep 2025−587.9%
Dec 2025−390.5%
Apr 2026−577.6%
Jul 2026−479.8%

Change on a year earlier (points)

  • Change on a year earlier (points) +96.4 pts
Change on a year earlier (points)
QuarterChange on a year earlier (points)
Oct 2023+3,97,306.5 pts
Dec 2023–
Mar 2024+2,99,896.2 pts
Jun 2024+1,11,595.1 pts
Sep 2024+22,624.6 pts
Dec 2024+118.7 pts
Mar 2025+459.5 pts
Jun 2025+766.8 pts
Sep 2025+468.5 pts
Dec 2025−35.3 pts
Apr 2026+257.2 pts
Jul 2026+96.4 pts
Top: quarterly operating margin, %. Below: change on the same quarter a year earlier, in percentage points. Last 12 quarters. Operating profit as a share of revenue, each quarter.

Is Enovix's profit turning into cash?

Enovix Corporation's cash-flow history is too short to judge how much of its profit turns into cash. In FY25 its operations used $95.3 M of cash, against −$157 M of profit. After $18.2 M of spending on assets, free cash was −$114 M: it spent more than its operations brought in.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

FY25: operating cash −$95.3 M against profit −$157 M

  • Operating cash −$95.3 M
  • Net profit −$157 M
  • Free cash −$114 M
FY25: operating cash −$95.3 M against profit −$157 M
QuarterOperating cashNet profitFree cash
FY23−$82.7 M−$51.6 M−$119 M
FY23−$105 M−$214 M−$166 M
FY24−$109 M−$222 M−$185 M
FY25−$95.3 M−$157 M−$114 M
Operating cash flow and net profit each year, $ M. The line is free cash flow: operating cash minus spending on assets. 4-year window, yearly figures.

Jul 2026: operating cash −$21.8 M

  • Operating cash (quarterly) −$21.8 M
Jul 2026: operating cash −$21.8 M
QuarterOperating cash (quarterly)
Oct 2023−$28.2 M
Dec 2023−$27.2 M
Mar 2024−$35.0 M
Jun 2024−$26.9 M
Sep 2024−$30.7 M
Dec 2024−$16.0 M
Mar 2025−$16.9 M
Jun 2025−$25.9 M
Sep 2025−$25.5 M
Dec 2025−$27.0 M
Apr 2026−$33.1 M
Jul 2026−$21.8 M
Operating cash each quarter, $ M. Last 12 quarters.

What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building.

Where does Enovix's cash go?

Enovix Corporation does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $156 M on assets over the last 3 years. Averaged over those years that is 163.6% of FY25 revenue a year.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn.

Spending on assets: $156 M over the last 3 years.

FY25: capex $18.2 M, down from the year before

  • Capex $18.2 M
FY25: capex $18.2 M, down from the year before
QuarterCapex
FY23$36.2 M
FY23$61.8 M
FY24$76.2 M
FY25$18.2 M
Capital spending each year, $ M.

Jul 2026: capex $9.6 M in the quarter

  • Capex (quarterly) $9.6 M
Jul 2026: capex $9.6 M in the quarter
QuarterCapex (quarterly)
Oct 2023$17.3 M
Dec 2023$28.8 M
Mar 2024$15.1 M
Jun 2024$25.2 M
Sep 2024$19.5 M
Dec 2024$16.4 M
Mar 2025$6.3 M
Jun 2025$8.0 M
Sep 2025$3.0 M
Dec 2025$1.0 M
Apr 2026$3.2 M
Jul 2026$9.6 M

Free cash

  • Free cash −$31.4 M
Free cash
QuarterFree cash
Oct 2023−$45.5 M
Dec 2023−$56.0 M
Mar 2024−$50.1 M
Jun 2024−$52.2 M
Sep 2024−$50.2 M
Dec 2024−$32.3 M
Mar 2025−$23.2 M
Jun 2025−$33.8 M
Sep 2025−$28.5 M
Dec 2025−$28.0 M
Apr 2026−$36.3 M
Jul 2026−$31.4 M
Top: capital spending each quarter, $ M. Below: free cash flow, $ M. Last 12 quarters.

In short: most of the cash goes on covering the loss, not on new assets; spending on assets is small next to it.

What is Enovix's P/E ratio, and how does it compare with its own history?

Enovix Corporation has no P/E right now, because its earnings are negative. The revenue and margin sections are where a turn would show first. Measured against sales instead, the market values Enovix Corporation at 18.8× its FY25 revenue of $31.8 M. The P/E comes back here once profit turns positive.

P/E is the share price divided by a year's profit per share: how many dollars the market pays for each dollar of yearly profit.

—P/E · earnings negative
n/mPEG · cannot be worked out, because 3-year earnings growth is not available

Is the Enovix business getting better or worse?

Enovix Corporation's business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 10 quarters of 2 measures, with some gaps.

Every business is somewhere on a path of getting better or worse, and this section names where. The last 12 quarters of growth in revenue, profit and earnings per share, plus the return the business earns on its capital, are read as lines. Getting worse: the lines are falling. Turning around: a low point has just formed and the last few quarters are rising from it. Getting better: the rise from the low has lasted. Growing steadily: steady growth with healthy returns. Slowing from a peak: still high, but slowing. When the lines disagree the result is mixed; too little history means no reading. CAGR (compound annual growth rate) is the steady yearly rate that would turn the starting value into the latest one. It is the fairest way to compare growth over different periods. If the 1-year figure is much bigger than the 10-year one, recent growth is running faster than the long-run trend. A dash means there is no figure for that period, or the starting year was a loss, where a growth rate means nothing.

Growth year by year: revenue +37.9% in FY25

  • Revenue growth 37.9%
Growth year by year: revenue +37.9% in FY25
QuarterRevenue growth
FY23–
FY2323.3%
FY24201.9%
FY2537.9%
Growth on the year before, each year, %. Top: revenue. Zero line drawn.

Three growth lines over twelve quarters: revenue rolling over

  • Revenue 34.9%
Three growth lines over twelve quarters: revenue rolling over
QuarterRevenue
Oct 2023–
Dec 2023–
Mar 2024107.2%
Jun 2024300%
Sep 2024300%
Dec 2024201.9%
Mar 202577.6%
Jun 202560%
Sep 202546%
Dec 202537.9%
Apr 202649.9%
Jul 202634.9%
Growth on a year earlier, % at each quarter end. Top: revenue. Each is measured over the last 12 months. Extreme jumps from a tiny base are drawn at the edge (▲). A gap means there is no reading for that quarter.

ROE: the return line, yearly figures

  • ROE −57.2%
ROE: the return line, yearly figures
QuarterROE
FY23−14.5%
FY23−82%
FY24−89.1%
FY25−57.2%
Yearly figures: the quarterly balance-sheet figures this line needs are not available for this stock, so it changes once a year and counts for less in the reading.
Turning downRevenue growth · latest +34.9%, range +34.9% to +1,429.4%
Stuck lowROE · latest −57.2%, range −89.1% to −14.5%

Why it matters: with too little history, we say so rather than guess a direction.

The latest quarter’s profit includes a one-off item bigger than the normal business, so the profit line is shown but does not count in this reading.

The return figures here are yearly, not quarterly. They show level and direction only; they can support the growth lines but never decide the reading alone.

There are fewer than eight usable quarters, so this page does not guess a direction from so little history.

Compound annual growth rate (%)

Compound annual growth rate over each period, %. Revenue, profit and EPS come from yearly figures; the stock price row is price growth over the same periods. A dash means no figure for that period, or the starting year was a loss.

Compound annual growth rate (%)
Measure1yr3yr5yr10yr
Revenue+37.9%———
Stock price−70.8%———
+20.8%Revenue growth (Jul 2026) · latest quarter against a year ago
126.5%Revenue, 2 years · yearly growth over the long run

How much does Enovix earn on its capital?

Enovix Corporation earned a ROE of −57% in FY25. That is up from a low of −89% in FY24. Its return on capital used (ROIC) is 30.9 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses.

Return on equity (ROE) is the profit the business earns on its shareholders’ money. We do not have the full capital split, so ROE is the longest history we can draw here.

It comes from a −492.6% net margin and 0.04× asset turnover (sales divided by assets).

Why the return is what it is (FY25): a −492.6% net margin × 0.04× asset turnover × 3.21× leverage (assets divided by equity) ≈ −63.2% on equity. The margin does its share; borrowing is a big part of it.

The key test, return on capital used minus the cost of capital: −19.3% − 11.6% = −30.9 percentage points. The 11.6% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve.

FY25: ROE −57%, the climb back from FY24's −89%

  • ROE −57.2%
  • Cost of capital 11.6%
FY25: ROE −57%, the climb back from FY24's −89%
QuarterROECost of capital
FY23−14.5%11.6%
FY23−82%11.6%
FY24−89.1%11.6%
FY25−57.2%11.6%
Return on equity each year, % (line). 4-year window, low years included. The flat line is the 11.6% cost of capital used on this page.

Jul 2026: ROE −59.2% (last 12 months)

  • ROE (12 months) −59.2%
Jul 2026: ROE −59.2% (last 12 months)
QuarterROE (12 months)
Oct 2023−92%
Dec 2023−25.9%
Mar 2024−93.5%
Jun 2024−75.4%
Sep 2024−228.9%
Dec 2024−52.8%
Mar 2025−71.4%
Jun 2025−38.6%
Sep 2025−79.7%
Dec 2025−85.4%
Apr 2026−49.1%
Jul 2026−59.2%
ROE over the last 12 months, each quarter, %. Last 12 quarters, lined up with the yearly figure.

Does Enovix have too much debt?

Enovix Corporation has total debt of $542 M against shareholder equity of $212 M as of Jul 2026, so its debt is 2.56× its equity. Year by year, that ratio went from 0.03 in FY22 to 1.99 in FY25. Keep that borrowing in mind when reading the returns on this page.

Debt-to-equity shows how much of the business is paid for with borrowed money. Lower is safer, and the direction matters as much as the level.

FY25: debt $544 M, 1.99× equity

  • Total debt $544 M
FY25: debt $544 M, 1.99× equity
QuarterTotal debt
FY22$9.1 M
FY23$8.2 M
FY23$191 M
FY24$193 M
FY25$544 M

Debt-to-equity

  • Debt-to-equity 1.99×
Debt-to-equity
QuarterDebt-to-equity
FY220.03×
FY230.02×
FY230.73×
FY240.77×
FY251.99×
Top: total debt each year, $ M. Below: debt-to-equity, ×. 5-year window.

Jul 2026: debt $542 M, debt-to-equity 2.56

  • Total debt (quarterly) $542 M
Jul 2026: debt $542 M, debt-to-equity 2.56
QuarterTotal debt (quarterly)
Oct 2023$176 M
Dec 2023$191 M
Mar 2024$194 M
Jun 2024$196 M
Sep 2024$197 M
Dec 2024$193 M
Mar 2025$195 M
Jun 2025$195 M
Sep 2025$543 M
Dec 2025$544 M
Apr 2026$544 M
Jul 2026$542 M

Debt-to-equity

  • Debt-to-equity 2.56×
Debt-to-equity
QuarterDebt-to-equity
Oct 20230.70×
Dec 20230.73×
Mar 20240.84×
Jun 20241.13×
Sep 20241.16×
Dec 20240.77×
Mar 20250.82×
Jun 20250.94×
Sep 20251.83×
Dec 20251.99×
Apr 20262.24×
Jul 20262.56×
Top: total debt each quarter, $ M. Below: debt-to-equity, ×. Last 12 quarters.

What is the Enovix shareholding pattern?

30.3% of Enovix Corporation's tradable shares are in short positions, which are bets that the price will fall, so a large group of traders is betting against it. At normal trading volumes, closing those positions would take about 7.0 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead.

There is no quarter-by-quarter list of owners here, so we look at short interest: the share of tradable shares held in short positions, which gain if the price falls.

It is a single reading at one point in time; we do not have its history.

30.3%Short interest · of the tradable float
7.0Days to cover · at typical volumes

Why it is at this level: the figure does not say who has the short positions or why, so we show the level without guessing the story.

How far is Enovix from balance-sheet trouble?

For Enovix Corporation, the Z-score is −0.09. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is in the danger zone. It estimates how far the balance sheet is from trouble; it is not a forecast of failure.

The Z-score estimates how far a company is from balance-sheet trouble. Above about 3 is safe; below about 1.8 is the danger zone. It was built for manufacturers, so it is not used for banks and lenders.

Why it matters: a Z-score of −0.09 is inside the danger zone, so the balance sheet is a real risk.

How does Enovix rank in its industry?

39.4 out of 100, rank 20 of 30 in Electrical Equipment & Parts, with 58% of the evidence available.

Enovix Corporation scores 39.4 out of 100 against the 30 companies it is compared with in Electrical Equipment & Parts, ranking 20. Some evidence is missing, so the score is pulled toward the middle on purpose.

The four parts add up to the total exactly: 17.1 + 5 + 11.5 + 5.8 = 39.4. This is the same number shown on the industry page; it is worked out once for the whole group and read here.

What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector.

Which companies is Enovix compared with?

Enovix ranks 20 of 30 Electrical Equipment & Parts companies on the 4-Factor Sector Score, with 39.4 out of 100.

  1. 1Acuity Inc.AYI · basing · Most evidence points up · 85% evidence73.7out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 22.9/35 · Revenue 6.8% · Profit 34% · Operating margin change 3.6 points · 95% evidenceCapital efficiency 18.8/25 · ROCE 18.3% · Operating margin 16.1% · 76% evidenceValuation 14.8/20 · P/E 18.6× · PEG 0.51 · 65% evidenceRelative strength 17.2/20 · Lead over its industry 22.1% · Lead over S&P 500 -1% · 1 year -6.4% · 100% evidence · 3 of 12 weeks aheadExact sum: 22.9 + 18.8 + 14.8 + 17.2 = 73.7 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks.
  2. 2Hayward Holdings, Inc.HAYW · turning · Most evidence points up · 81% evidence65.6out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 18.3/35 · Revenue 7.6% · Profit 22.9% · Operating margin change -0.2 points · 83% evidenceCapital efficiency 14.8/25 · ROCE 8.8% · Operating margin 24.1% · 76% evidenceValuation 13.2/20 · P/E 22.2× · PEG 0.8 · 65% evidenceRelative strength 19.3/20 · Lead over its industry 31.8% · Lead over S&P 500 6.5% · 1 year 6.9% · 100% evidence · 2 of 12 weeks aheadExact sum: 18.3 + 14.8 + 13.2 + 19.3 = 65.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  3. 3Espey Mfg. & Electronics Corp.ESP · quiet · Evidence leans up · 81% evidence63.8out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 16.6/35 · Revenue 2.3% · Profit 22.2% · Operating margin change -1.6 points · 83% evidenceCapital efficiency 19.6/25 · ROCE 19.1% · Operating margin 25.8% · 76% evidenceValuation 14.6/20 · P/E 17× · PEG 0.58 · 65% evidenceRelative strength 13.0/20 · Lead over its industry 3.5% · Lead over S&P 500 -16.9% · 1 year 33.8% · 100% evidence · 3 of 12 weeks aheadExact sum: 16.6 + 19.6 + 14.6 + 13 = 63.8 · What this means: Relative strength against the index is -16.9%, and revenue and profit growth are weak.
  4. 4Vertiv Holdings CoVRT · quiet · Evidence leans up · 71% evidence62.2out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 26.1/35 · Revenue 26.2% · Profit 100% · Operating margin change 3.5 points · 83% evidenceCapital efficiency 20.6/25 · ROCE 26.5% · Operating margin 20.4% · 76% evidenceValuation 9.0/20 · P/E 74.3× · PEG — · 15% evidenceRelative strength 6.5/20 · Lead over its industry -3% · Lead over S&P 500 -22.7% · 1 year 14.3% · 100% evidence · 0 of 12 weeks aheadExact sum: 26.1 + 20.6 + 9 + 6.5 = 62.2 · What this means: Earnings are strong; relative strength in its sector is -3% and the one-year return is 14.3%.
  5. 5Bloom Energy CorporationBE · losing its lead · Evidence leans up · 67% evidence61.6out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 25.9/35 · Revenue 100% · Profit 100% · Operating margin change 17 points · 71% evidenceCapital efficiency 13.5/25 · ROCE 11.3% · Operating margin 18.5% · 76% evidenceValuation 8.7/20 · P/E 157.4× · PEG — · 15% evidenceRelative strength 13.5/20 · Lead over its industry 21.3% · Lead over S&P 500 -3.4% · 1 year 48.2% · 100% evidence · 2 of 12 weeks aheadExact sum: 25.9 + 13.5 + 8.7 + 13.5 = 61.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  6. 6Kimball Electronics, Inc.KE · quiet · Evidence leans up · 81% evidence58.1out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 16.4/35 · Revenue -3.6% · Profit 70.6% · Operating margin change -0.4 points · 83% evidenceCapital efficiency 10.8/25 · ROCE 7.5% · Operating margin 4.2% · 76% evidenceValuation 15.0/20 · P/E 22× · PEG 0.46 · 65% evidenceRelative strength 15.9/20 · Lead over its industry 14.2% · Lead over S&P 500 -7.6% · 1 year -5% · 100% evidence · 4 of 12 weeks aheadExact sum: 16.4 + 10.8 + 15 + 15.9 = 58.1 · What this means: Relative strength against the index is -7.6%, and revenue and profit growth are weak.
  7. 7EnerSysENS · quiet · Too little evidence to rank firmly · 58% evidence57.9out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 19.4/35 · Revenue — · Profit — · Operating margin change 2.1 points · 45% evidenceCapital efficiency 17.5/25 · ROCE 15.8% · Operating margin 14% · 76% evidenceValuation 10.2/20 · P/E 21.4× · PEG — · 15% evidenceRelative strength 10.8/20 · Lead over its industry 0.4% · Lead over S&P 500 -19.7% · 1 year 18.2% · 100% evidence · 0 of 12 weeks aheadExact sum: 19.4 + 17.5 + 10.2 + 10.8 = 57.9 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose.
  8. 8Advanced Energy Industries, Inc.AEIS · quiet · Evidence leans up · 81% evidence56.2out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 26.8/35 · Revenue 24.5% · Profit 100% · Operating margin change 7.8 points · 83% evidenceCapital efficiency 14.1/25 · ROCE 10.4% · Operating margin 17% · 76% evidenceValuation 11.2/20 · P/E 64.6× · PEG 1 · 65% evidenceRelative strength 4.1/20 · Lead over its industry -13.9% · Lead over S&P 500 -31.3% · 1 year -2.4% · 100% evidence · 0 of 12 weeks aheadExact sum: 26.8 + 14.1 + 11.2 + 4.1 = 56.2 · What this means: Earnings are strong; relative strength in its sector is -13.9% and the one-year return is -2.4%.
  9. 9Preformed Line Products CompanyPLPC · losing its lead · Evidence leans up · 81% evidence51.6out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 18.2/35 · Revenue 16.9% · Profit 2.3% · Operating margin change 3.1 points · 83% evidenceCapital efficiency 15.4/25 · ROCE 11.8% · Operating margin 13.1% · 76% evidenceValuation 8.2/20 · P/E 46.6× · PEG 1.94 · 65% evidenceRelative strength 9.8/20 · Lead over its industry 5.8% · Lead over S&P 500 -15.1% · 1 year 36% · 100% evidence · 8 of 12 weeks aheadExact sum: 18.2 + 15.4 + 8.2 + 9.8 = 51.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  10. 10Energizer Holdings, Inc.ENR · breaking out · Evidence leans up · 71% evidence51.1out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 7.5/35 · Revenue 2.1% · Profit -67.5% · Operating margin change -17.4 points · 83% evidenceCapital efficiency 13.3/25 · ROCE 11.1% · Operating margin 12% · 76% evidenceValuation 10.5/20 · P/E 18× · PEG — · 15% evidenceRelative strength 19.8/20 · Lead over its industry 41.8% · Lead over S&P 500 15% · 1 year 5.7% · 100% evidence · 4 of 12 weeks aheadExact sum: 7.5 + 13.3 + 10.5 + 19.8 = 51.1 · What this means: Relative strength against the index is 15%, and revenue and profit growth are weak.
  11. 11Hubbell IncorporatedHUBB · quiet · Evidence leans up · 81% evidence50.7out of 100GrowthCapitalValuationRelative
  12. 12nVent Electric plcNVT · quiet · Evidence leans down · 81% evidence49.7out of 100GrowthCapitalValuationRelative
  13. 13Amprius Technologies, Inc.AMPX · quiet · Evidence leans down · 61% evidence46.7out of 100GrowthCapitalValuationRelative
  14. 14GrafTech International Ltd.EAF · turning · Evidence leans down · 67% evidence46.2out of 100GrowthCapitalValuationRelative
  15. 15Powell Industries, Inc.POWL · quiet · Evidence leans down · 81% evidence46.1out of 100GrowthCapitalValuationRelative
  16. 16Eos Energy Enterprises, Inc.EOSE · quiet · Evidence leans down · 64% evidence43.9out of 100GrowthCapitalValuationRelative
  17. 17NeoVolta Inc.NEOV · quiet · Too little evidence to rank firmly · 57% evidence43.5out of 100GrowthCapitalValuationRelative
  18. 18Plug Power Inc.PLUG · quiet · Evidence leans down · 61% evidence41.4out of 100GrowthCapitalValuationRelative
  19. 19Ballard Power Systems Inc.BLDP · basing · Too little evidence to rank firmly · 50% evidence40.5out of 100GrowthCapitalValuationRelative
  20. 20Enovix Corporation this pageENVX · basing · Too little evidence to rank firmly · 58% evidence39.4out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 17.1/35 · Revenue — · Profit — · Operating margin change 108.1 points · 45% evidenceCapital efficiency 5.0/25 · ROCE -23.8% · Operating margin -479.8% · 76% evidenceValuation 11.5/20 · P/E -34.4× · PEG — · 15% evidenceRelative strength 5.8/20 · Lead over its industry -42.2% · Lead over S&P 500 -53.9% · 1 year -70.8% · 100% evidence · 0 of 12 weeks aheadExact sum: 17.1 + 5 + 11.5 + 5.8 = 39.4 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose.
  21. 21Atkore Inc.ATKR · Too little evidence to rank firmly · 51% evidence39.4out of 100GrowthCapitalValuationRelative
  22. 22Electrovaya Inc.ELVA · quiet · Evidence leans down · 71% evidence38.7out of 100GrowthCapitalValuationRelative
  23. 23ADS-TEC Energy PLCADSE · basing · Too little evidence to rank firmly · 51% evidence36.2out of 100GrowthCapitalValuationRelative
  24. 24FuelCell Energy, Inc.FCEL · quiet · Most evidence points down · 64% evidence34.6out of 100GrowthCapitalValuationRelative
  25. 25T1 Energy Inc.TE · basing · Too little evidence to rank firmly · 58% evidence33.7out of 100GrowthCapitalValuationRelative
  26. 26Forgent Power Solutions, Inc.FPS · quiet · Too little evidence to rank firmly · 44% evidence58.6out of 100GrowthCapitalValuationRelative
  27. 27Arxis, Inc.ARXS · quiet · Too little evidence to rank firmly · 28% evidence42.3out of 100GrowthCapitalValuationRelative
  28. 28X-Energy, Inc.XE · quiet · Too little evidence to rank firmly · 26% evidence40.2out of 100GrowthCapitalValuationRelative
  29. 29Factorial Energy Inc.FAC · basing · Too little evidence to rank firmly · 21% evidence38.6out of 100GrowthCapitalValuationRelative
  30. 30Lightbridge CorporationLTBR · quiet · Too little evidence to rank firmly · 47% evidence38.0out of 100GrowthCapitalValuationRelative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read.

The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section.

Related companies: Electrical Equipment & Parts, all 30 compared on one page.

Which companies are close to Enovix in size?

Enovix is the 23rd largest of 27 Electrical Equipment & Parts companies on Sector Alpha by market value (scores of 4 November 2026). Just above it: Eos Energy Enterprises, Inc., ADS-TEC Energy PLC and Kimball Electronics, Inc. Just below it: Ballard Power Systems Inc., GrafTech International and Electrovaya Inc.

Electrical Equipment & Parts companies close in size

  1. Eos Energy Enterprises, Inc. $779 million
  2. ADS-TEC Energy PLC $681 million
  3. Kimball Electronics, Inc. $620 million
  4. Enovix Corporation $597 million
  5. Ballard Power Systems Inc. $556 million
  6. GrafTech International Ltd. $286 million
  7. Electrovaya Inc. $254 million

All 27 Electrical Equipment & Parts companies, largest first

Companies close in size in other industries

  1. Unity Bancorp, Inc. $598 million · Banks - Regional
  2. Stratasys Ltd. $597 million · Computer Hardware
  3. Enovix Corporation $597 million
  4. Civista Bancshares, Inc. $597 million · Banks - Regional
  5. IBEX Limited $594 million · Information Technology Services

What else do people ask about Enovix?

What were Enovix's latest quarterly results?

Enovix Corporation reported revenue of $9.0 M and a net loss of $43.1 M for the Jul 2026 quarter. Earnings per share were −$0.20. The operating margin was −479.8%, 96.4 percentage points higher than a year earlier (as of 4 November 2026).

What is Enovix's market cap?

Enovix Corporation's market capitalisation is $597 M at a stock price of $2.79. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 4 November 2026).

How is Enovix performing?

Enovix Corporation's latest readings are below. Over the past 13 weeks it has done worse than the S&P 500, for 20 weeks running. This describes what the data did, not a rating (as of 4 November 2026).

Will Enovix's stock price go up?

This page does not forecast Enovix Corporation's stock price. What it shows instead: the stock price is $2.79. Nobody can reliably say which way a price will move, and this site does not try (as of 4 November 2026).

Where is Enovix in its business cycle?

Enovix Corporation's FY25 operating margin was −554.8%, against a 4-year range of −2,656.0% to −554.8%: the middle of its own range, neither a peak nor a low. The latest quarter was −479.8%.

Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 4 November 2026).

What could break the Enovix story?

Biggest thing to watch: the price is not yet in a clear uptrend, so timing is the risk more than the business.

On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 4 November 2026).

Is Enovix a stock worth studying right now?

What the numbers show: Enovix Corporation's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: the next one or two quarters of results.

Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 4 November 2026).

Where do these numbers come from?

Sector Alpha, written by code from the published numbers. Data as of 4 November 2026.

Every chart on this page is drawn by code from the published figures, with no forecasts and no price opinions.

See the plain-text version of this page.

More lists

Every Sector Alpha list, grouped

X · Instagram · YouTube · About · Newsletter · Newsletter archive
This is research, not advice. We’re not SEBI-registered.